Ticker Details
Amneal Pharmaceuticals, Inc.
IPO Date:	January 1, 1900
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$6.24B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.19 | 2.85%
Avg Daily Range (30 D):	$0.42 | 2.33%
Avg Daily Range (90 D):	$0.34 | 2.19%

Institutional Daily Volume
Avg Daily Volume:	1.26M
Avg Daily Volume (30 D):	1.42M
Avg Daily Volume (90 D):	1.39M

Trade Size
Avg Trade Size (Sh.):	131
Avg Trade Size (Sh.) (30 D):	66
Avg Trade Size (Sh.) (90 D):	69

Institutional Trades
Total Institutional Trades:	2,230
Avg Institutional Trade:	$2.07M
Avg Institutional Trade (30 D):	$3.89M
Avg Institutional Trade (90 D):	$3.43M
Avg Institutional Trade Volume:	.21M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.58M
Avg Closing Trade (30 D):	$6.61M
Avg Closing Trade (90 D):	$6.12M
Avg Closing Volume:	250.67K

News

Jul 17, 2026 @ 12:00 PM Amneal Expands Iohexol Injection Portfolio with U.... Source: Not Specified

Jun 4, 2026 @ 5:00 PM IgE Receptor Antagonists Clinical Trial Pipeline A... Source: Delveinsight

Apr 22, 2026 @ 11:15 AM Why Is Amneal Pharmaceuticals Stock Gaining Today?... Source: Nabaparna Bhattacharya

Apr 14, 2026 @ 12:00 PM Amneal Launches First Two Respiratory Metered-Dose... Source: Not Specified

Feb 13, 2026 @ 4:26 PM Accessible Health Platforms Gain Scale Across $6T ... Source: Prnewswire

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$.18	$.2	$.11
Diluted EPS	$.18	$.19	$.11
Revenue	$796.2M	$722.52M	$814.32M
Gross Profit	$334.51M	$320.11M	$297.19M
Net Income / Loss	$69.61M	$78M	$49.57M
Operating Income / Loss	$129.77M	$141.77M	$112.03M
Cost of Revenue	$461.69M	$402.41M	$517.13M
Net Cash Flow	$-64.79M	$-108.53M	$74.53M
PE Ratio

Splits
Aug 26, 2013	1:25